<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04837625</url>
  </required_header>
  <id_info>
    <org_study_id>MC2020883</org_study_id>
    <nct_id>NCT04837625</nct_id>
  </id_info>
  <brief_title>A Multicenter Prospective Registration Study of Myasthenic Crisis in China</brief_title>
  <official_title>A Multicenter Prospective Registration Study of Myasthenic Crisis in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huashan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multicenter, prospective, observational research. It will register the basic&#xD;
      demographic information, medical history characteristics, clinical features, auxiliary&#xD;
      examinations, treatment, outcomes of tracheal intubation/ventilator related events, and&#xD;
      clinical outcomes of Myasthenic Crisis patients. The objectives including:&#xD;
&#xD;
        1. Obtain epidemiological data of MC in China;&#xD;
&#xD;
        2. Establish a standardized registration system for MC patients in China;&#xD;
&#xD;
        3. Explore the epidemiology, clinical characteristics, serological characteristics,&#xD;
           clinical characteristics of MC, predisposing and predictive factors, extubation&#xD;
           process/time, weaning/extubation outcome and predictors of clinical outcome in Chinese&#xD;
           MC patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MG-ADL of 3 years after off-mechanical ventilation</measure>
    <time_frame>Sep,2026</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myasthenia Gravis</condition>
  <condition>Myasthenic Crisis</condition>
  <arm_group>
    <arm_group_label>Myasthenic Crisis Cohort</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no interventions</intervention_name>
    <description>no interventions</description>
    <arm_group_label>Myasthenic Crisis Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be recruited from multiple centers across China.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  (1)clinical history and signs of fluctuating weakness and fatigability;&#xD;
             (2)seropositivityforAChR/MuSKantibodies; (3)If negative or the tested antibodies,&#xD;
             positive repetitive nerve stimulation(RNS) at low frequency(2-5Hz) is required; (4)A&#xD;
             serious, life-threatening, rapid worsening of MG and potential airway compromise from&#xD;
             ventilatory or bulbar dysfunction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  the RNS had over 100% increase after high frequency stimulation or R2 repeats,to&#xD;
             differentiate from lambert-Eaton syndrome and congenital MG.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiao Huan, MD</last_name>
    <phone>+8618351973910</phone>
    <email>hx941223@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Susan Luo, MD;PHD</last_name>
    <email>SusanRo_36@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Huashan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiao Huan, MD</last_name>
      <email>hx941223@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Susan Luo, MDï¼›PHD</last_name>
      <email>SusanRo_36@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 6, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huashan Hospital</investigator_affiliation>
    <investigator_full_name>Chongbo Zhao</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myasthenia Gravis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

